Keywords
Last Name
Institution

JONATHAN MICHAEL LEVITT

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pathology & Immunology
DivisionImmunology
AddressDepartment of Pathology & Immunology
One Baylor Plaza
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleAssociate Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Urology
    DivisionUrology


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Liang D, Tian L, You R, Halpert MM, Konduri V, Baig YC, Paust S, Kim D, Kim S, Jia F, Huang S, Zhang X, Kheradmand F, Corry DB, Gilbert BE, Levitt JM, Decker WK. AIMp1 Potentiates TH1 Polarization and Is Critical for Effective Antitumor and Antiviral Immunity. Front Immunol. 2017; 8:1801. PMID: 29379495.
      View in: PubMed
    2. Konduri V, Halpert MM, Liang D, Levitt JM, Cruz JVC, Zhan B, Bottazzi ME, Hotez PJ, Jones KM, Decker WK. Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy. Infect Immun. 2017 Jul 03. PMID: 28674032.
      View in: PubMed
    3. Sonpavde G, McMannis JD, Bai Y, Seethammagari MR, Bull JMC, Hawkins V, Dancsak TK, Lapteva N, Levitt JM, Moseley A, Spencer DM, Slawin KM. Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer. Cancer Immunol Immunother. 2017 Jun 12. PMID: 28608115.
      View in: PubMed
    4. Collinson-Pautz MR, Slawin KM, Levitt JM, Spencer DM. MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity. PLoS One. 2016; 11(10):e0164547. PMID: 27741278.
      View in: PubMed
    5. Konduri V, Li D, Halpert MM, Liang D, Liang Z, Chen Y, Fisher WE, Paust S, Levitt JM, Yao QC, Decker WK. Chemo-immunotherapy mediates durable cure of orthotopic Kras(G12D)/p53(-/-) pancreatic ductal adenocarcinoma. Oncoimmunology. 2016; 5(9):e1213933. PMID: 27757308.
      View in: PubMed
    6. Halpert MM, Konduri V, Liang D, Chen Y, Wing JB, Paust S, Levitt JM, Decker WK. Dendritic Cell-Secreted Cytotoxic T-Lymphocyte-Associated Protein-4 Regulates the T-cell Response by Downmodulating Bystander Surface B7. Stem Cells Dev. 2016 May 15; 25(10):774-87. PMID: 26979751; PMCID: PMC4870609 [Available on 05/15/17].
    7. von Rundstedt FC, Rajapakshe K, Ma J, Arnold JM, Gohlke J, Putluri V, Krishnapuram R, Piyarathna DB, Lotan Y, Gödde D, Roth S, Störkel S, Levitt JM, Michailidis G, Sreekumar A, Lerner SP, Coarfa C, Putluri N. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival. J Urol. 2016 Jun; 195(6):1911-9. PMID: 26802582; PMCID: PMC4861129.
    8. Jian W, Xu HG, Chen J, Xu ZX, Levitt JM, Stanley JA, Yang ES, Lerner SP, Sonpavde G. Activity of CEP-9722, a poly (ADP-ribose) polymerase inhibitor, in urothelial carcinoma correlates inversely with homologous recombination repair response to DNA damage. Anticancer Drugs. 2014 Sep; 25(8):878-86. PMID: 24714082.
      View in: PubMed
    9. Jian W, Levitt JM, Lerner SP, Sonpavde G. The angiopoietin-TIE2 pathway is a potential therapeutic target in urothelial carcinoma. Anticancer Res. 2014 Jul; 34(7):3377-82. PMID: 24982343.
      View in: PubMed
    10. Jian W, Levitt JM, Lerner SP, Sonpavde G. The preclinical activity of lenalidomide in indolent urothelial carcinoma. Anticancer Res. 2014 Jul; 34(7):3383-9. PMID: 24982344.
      View in: PubMed
    11. Carstens JL, Shahi P, Van Tsang S, Smith B, Creighton CJ, Zhang Y, Seamans A, Seethammagari M, Vedula I, Levitt JM, Ittmann MM, Rowley DR, Spencer DM. FGFR1-WNT-TGF-? signaling in prostate cancer mouse models recapitulates human reactive stroma. Cancer Res. 2014 Jan 15; 74(2):609-20. PMID: 24305876; PMCID: PMC3905049.
    12. Kemnade JO, Seethammagari M, Narayanan P, Levitt JM, McCormick AA, Spencer DM. Off-the-shelf adenoviral-mediated immunotherapy via bicistronic expression of tumor antigen and iMyD88/CD40 adjuvant. Mol Ther. 2012 Jul; 20(7):1462-71. PMID: 22434138; PMCID: PMC3392976.
    13. Chiou SH, Shahi P, Wagner RT, Hu H, Lapteva N, Seethammagari M, Sun SC, Levitt JM, Spencer DM. The E3 ligase c-Cbl regulates dendritic cell activation. EMBO Rep. 2011 Sep; 12(9):971-9. PMID: 21799517; PMCID: PMC3166462.
    14. Levitt JM, Jian W, Lerner SP, Sonpavde G. A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinoma. Urol Oncol. 2013 Feb; 31(2):234-40. PMID: 21723160.
      View in: PubMed
    15. Narayanan P, Lapteva N, Seethammagari M, Levitt JM, Slawin KM, Spencer DM. A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy. J Clin Invest. 2011 Apr; 121(4):1524-34. PMID: 21383499; PMCID: PMC3069772.
    16. Ramachandran IR, Song W, Lapteva N, Seethammagari M, Slawin KM, Spencer DM, Levitt JM. The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell function. J Immunol. 2011 Apr 1; 186(7):3934-45. PMID: 21357539.
      View in: PubMed
    17. Levitt JM, Yamashita H, Jian W, Lerner SP, Sonpavde G. Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signaling. Mol Cancer Ther. 2010 May; 9(5):1128-35. PMID: 20406945.
      View in: PubMed
    18. Sonpavde G, Slawin KM, Spencer DM, Levitt JM. Emerging vaccine therapy approaches for prostate cancer. Rev Urol. 2010; 12(1):25-34. PMID: 20428291; PMCID: PMC2859139.
    19. Jian W, Yamashita H, Levitt JM, Lerner SP, Sonpavde G. Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine. Mol Cancer Ther. 2009 Jul; 8(7):1772-8. PMID: 19509273.
      View in: PubMed
    20. Mullins C, Lucia MS, Hayward SW, Lee JY, Levitt JM, Lin VK, Liu BC, Chinnaiyan AM, Rubin MA, Slawin K, Star RA, Getzenberg RH. A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium. J Urol. 2008 Apr; 179(4):1243-56. PMID: 18280515; PMCID: PMC3105378.
    21. Lapteva N, Seethammagari MR, Hanks BA, Jiang J, Levitt JM, Slawin KM, Spencer DM. Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation. Cancer Res. 2007 Nov 1; 67(21):10528-37. PMID: 17974997.
      View in: PubMed
    22. Levitt JM, Slawin KM. Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression. Curr Urol Rep. 2007 Jul; 8(4):269-74. PMID: 18519010.
      View in: PubMed
    23. Vavra AK, Laurent CJ, Ngo V, Sweeney JF, Levitt JM. Sulfur mustard primes phagocytosis and degranulation in human polymorphonuclear leukocytes. Int Immunopharmacol. 2004 Mar; 4(3):437-45. PMID: 15037221.
      View in: PubMed
    24. Levitt JM, Lodhi IJ, Nguyen PK, Ngo V, Clift R, Hinshaw DB, Sweeney JF. Low-dose sulfur mustard primes oxidative function and induces apoptosis in human polymorphonuclear leukocytes. Int Immunopharmacol. 2003 May; 3(5):747-56. PMID: 12757743.
      View in: PubMed
    25. Levitt JM, Howell DD, Rodgers JR, Rich RR. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules. Eur J Immunol. 2001 Apr; 31(4):1181-90. PMID: 11298343.
      View in: PubMed
    26. Howell D, Levitt JM, Foster PA, Guenther MM, Shawar SM, Rich RR, Rodgers JR. Heterogeneity of RMA-S cell line: derivatives of RMA-S cells lacking H2-Kb and H2-Db expression. Immunogenetics. 2000 Nov; 52(1-2):150-4. PMID: 11132152.
      View in: PubMed
    27. Wang C, Bogue MA, Levitt JM, Roth DB. Irradiation-mediated rescue of T cell-specific V(D)J recombination and thymocyte differentiation in severe combined immunodeficient mice by bone marrow cells. J Exp Med. 1999 Nov 1; 190(9):1257-62. PMID: 10544197; PMCID: PMC2195679.
    28. Rodgers JR, Levitt JM, Cresswell P, Lindahl KF, Mathis D, Monaco JT, Singer DS, Ploegh HL, Bryant PW. A nomenclature solution to mouse MHC confusion. J Immunol. 1999 May 15; 162(10):6294. PMID: 10375304.
      View in: PubMed
    29. Levitt, J. M. and Arp, A. J. The effects of sulfide on the anaerobic metabolism of two congeneric species of mudflat clams. Comp. Biochem. Physiol. B. 1991; 98(2-3):339-348.
    LEVITT's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _